# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Raymond James analyst Michael Rose initiates coverage on Firstsun Capital (NASDAQ:FSUN) with a Market Perform rating.
No Action Required From Shareholders
an increase in FirstSun's total equity capital raised in connection with the merger of an additional $45 million to $60 mil...
Combined assets of approximately $17 billion Dallas, Texas headquartered bank with an extensive footprint in 6 of the top 10...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...